Semax 30mg

Researchers investigate Semax peptide within controlled laboratory environments to examine peptide signaling pathway mechanisms. Experimental peptide interaction models utilize this compound to study molecular communication processes in vitro. Controlled laboratory peptide stability studies assess compound properties under various experimental conditions. Scientists explore structural characteristics and signaling mechanisms in research settings. Laboratory personnel examine peptide behavior in experimental models designed for signaling pathway research. These investigations occur exclusively in controlled research environments without clinical applications.

Semax peptide is investigated in research environments to understand peptide signaling mechanisms. This compound is studied within controlled laboratory models examining molecular interaction pathways. Researchers explore this peptide for experimental peptide research applications in academic and institutional settings. Laboratory studies examine the compound’s signaling characteristics under standardized conditions. Scientists investigate structural properties relevant to peptide research protocols. All research applications remain confined to laboratory environments and experimental models.

Store Semax peptide in cool, dry conditions protected from light exposure. Storage temperature should remain consistent to maintain compound stability. Keep the product sealed until ready for laboratory use. Laboratory handling should occur only by qualified research personnel trained in peptide research protocols. Avoid exposure to moisture, heat, and direct sunlight during storage. Use appropriate laboratory equipment when handling this research compound. Reconstitution should follow standard laboratory peptide preparation procedures using sterile techniques. Maintain proper documentation of handling and storage conditions for research records. Dispose of unused material according to institutional laboratory waste protocols.

Each batch undergoes comprehensive purity verification procedures to confirm research-grade quality. Third-party testing validates compound purity at 99%+ by HPLC analysis. Batch-to-batch consistency ensures reliable results across research protocols. Certificate of Analysis accompanies each order documenting purity verification results. Internal quality assurance standards maintain strict compound specifications. Testing procedures verify molecular weight, purity percentage, and compound identity. Research-grade supply positioning ensures suitability for controlled laboratory investigations. Quality control documentation supports institutional research compliance requirements.

• CAS: 80714-61-0
• Chemical Formula: C₃₇H₅₁N₉O₁₀S
• Molecular Weight: 813.9 g/mol
• Peptide Sequence: Met-Glu-His-Phe-Pro-Gly-Pro
• Shelf life: 24 months from the manufacturing date.

Semax peptide is a synthetic peptide compound produced for research applications. A synthetic peptide is a laboratory-created chain of amino acids linked in a specific sequence. Peptide signaling refers to how these molecular structures interact with cellular receptors to initiate molecular responses in experimental models. Signaling peptides are studied in laboratory research because they help scientists understand how molecules communicate at the cellular level. This synthetic peptide origin ensures batch-to-batch consistency for research protocols. The compound consists of a defined amino acid sequence arranged for experimental study. Researchers examine this peptide’s properties within controlled laboratory conditions without therapeutic context.

This synthetic research peptide formulation provides laboratories with a standardized compound for comprehensive experimental studies. The higher-quantity 30mg format supports extended research applications and multiple experimental protocols. Each batch undergoes rigorous purity verification to ensure consistency across research series. High-purity formulation meets research-grade standards for peptide signaling studies. Secure packaging protects compound integrity during storage and transport. Discreet shipment ensures confidential delivery to research facilities and institutional laboratories.

Semax is a synthetic heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from the N-terminal ACTH(4-10) sequence with a C-terminal Pro-Gly-Pro extension. ACTH(4-10) is the minimal melanocortin receptor-binding fragment of adrenocorticotropic hormone. The Pro-Gly-Pro tripeptide addition in Semax increases stability against proteolytic degradation while altering the pharmacological profile relative to the parent ACTH fragment.

Preclinical research has investigated Semax for interactions with melanocortin receptors — particularly MC4R expressed in the central nervous system — as well as effects on BDNF expression in neuronal cell models, neurotrophic signalling pathway activation (TrkB, PI3K/Akt, MAPK), and enkephalin-degrading enzyme inhibition. Research has also examined effects on gene expression in hippocampal and cortical neuronal preparations using transcriptomic approaches.

Published preclinical research has examined Semax’s effects on BDNF mRNA and protein expression in rat brain preparations and primary neuronal cultures, activation of CREB transcription factor as a downstream target of TrkB/cAMP signalling, and expression of other neurotrophic factors (NGF, NT-3) in hippocampal models. These studies use standard qRT-PCR, ELISA, and Western blot endpoints to characterise the compound’s effects on defined neurotrophic signalling parameters.

Semax is supplied as a lyophilised powder and should be stored at -20°C. It is generally soluble in sterile water or PBS at physiological pH. The presence of the N-terminal methionine makes it susceptible to oxidation — stock solutions should be prepared under nitrogen atmosphere where possible and stored in single-use aliquots at -80°C to prevent Met oxidation during storage.

Standard controls include vehicle alone (matched buffer without peptide), a scrambled sequence control to confirm sequence specificity, and reference compounds with established activity at the target pathway (e.g. recombinant BDNF for neurotrophic endpoint assays, α-MSH for melanocortin receptor assays). Concentration-response experiments over a minimum 4-log concentration range establish potency and confirm the dose-dependence of observed effects.

Semax has been used in clinical and research contexts in Russia. As supplied by Elivena, Semax is a research-grade compound for use in controlled laboratory settings only. It is not supplied for human administration outside of formally regulated research and clinical contexts.